Concord Medical - Spon ADRCCM
13F holders, Q3 2025 (September 30)4holders −1
1new positions
2sold out
$6.13avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Concord Medical - Spon ADR (CCM) in their 13F filings, down 1 from Q2 2025. 1 opened new positions and 2 sold out. The largest holders were UBS Group AG ($232K), Morgan Stanley ($614) and SBI Securities Co., Ltd. ($25).
- Company
- Concord Medical - Spon ADR
- CUSIP
- 206277204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 2 | $7K |
All 13F filers, Q2 2025 → Q3 2025: 37 shares bought and 31,248 shares sold, net −31,211 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| UBS Group AG | 0.00% | Reduce -44.3% | 37,848 | $232K |
| Morgan Stanley | 0.00% | No change | 100 | $614 |
| SBI Securities Co., Ltd. | 0.00% | No change | 4 | $25 |
| Bessemer Group Inc. | 0.00% | New | 37 | $0 |
"% of holder's portfolio" is CCM's weight in each manager's 13F, not the share of Concord Medical - Spon ADR the manager owns.